The FDA never should have allowed OxyContin and other opioids to be broadly marketed for chronic pain patients, Dr. David Kessler, the agency’s former commissioner, tells “60 Minutes.” “There are no studies on the safety or efficacy of opioids for long-term use,” Kessler tells Bill Whitaker. “The...